NGNE · Neurogene Inc. · Documents

Aug 11

Quarterly report 10-Q FY2026 Q2, ended Jun 30

Quarterly report for FY2026 Q2 AI summary on its way

Net loss $34.49M Diluted EPS -$1.53

Aug 11

Current report 8-K

Financial results AI summary on its way

Jul 2

Current report 8-K Events of Jun 30

Entered into a material agreement, Other events AI summary on its way

Jun 29

Current report 8-K

Regulation FD disclosure, Other events AI summary on its way

Jun 8

Current report 8-K

Regulation FD disclosure AI summary on its way

Jun 4

Current report 8-K Events of Jun 3

Shareholder vote results AI summary on its way

May 12

Current report 8-K

Financial results AI summary on its way

May 12

Quarterly report 10-Q FY2026 Q1, ended Mar 31

Quarterly report for FY2026 Q1 AI summary on its way

Net loss $30.93M Diluted EPS -$1.39

Apr 20

Current report 8-K

Director or officer change, or executive pay, Regulation FD disclosure AI summary on its way

Apr 16

Proxy statement DEF 14A Meeting Jun 3, 2026

Proxy statement AI summary on its way

Apr 16

Annual report to holders ARS

Annual report to holders AI summary on its way

Apr 16

Proxy statement DEFA14A

Proxy statement AI summary on its way

Mar 24

Current report 8-K

Financial results AI summary on its way

Mar 24

Annual report 10-K FY2025, ended Dec 31

Annual report for FY2025 AI summary on its way

Revenue $0 Net loss $90.35M Diluted EPS -$4.24

Feb 26

Current report 8-K

Regulation FD disclosure AI summary on its way

Jan 12

Current report 8-K

Regulation FD disclosure AI summary on its way

Nov 13

Current report 8-K

Financial results

Nov 13

Quarterly report 10-Q FY2025 Q3, ended Sep 30

Quarterly report for FY2025 Q3

Revenue $0 Net loss $20.95M Diluted EPS -$0.99

Nov 12

Current report 8-K

Regulation FD disclosure

Nov 6

Current report 8-K

Regulation FD disclosure

Oct 9

Current report 8-K

Regulation FD disclosure

Aug 11

Current report 8-K

Financial results

Aug 11

Quarterly report 10-Q FY2025 Q2, ended Jun 30

Quarterly report for FY2025 Q2

Revenue $0 Net loss $22.02M Diluted EPS -$1.05

Jun 30

Current report 8-K

Regulation FD disclosure

Jun 12

Current report 8-K

Director or officer change, or executive pay, Shareholder vote results

Jun 9

Current report 8-K

Other events

May 9

Current report 8-K

Financial results

May 9

Quarterly report 10-Q FY2025 Q1, ended Mar 31

Quarterly report for FY2025 Q1

Net loss $22.65M Diluted EPS -$1.08

Apr 25

Proxy statement DEF 14A

Proxy statement

Apr 25

Annual report to holders ARS

Annual report to holders

Apr 25

Proxy statement DEFA14A

Proxy statement

Apr 14

Current report 8-K

Entered into a material agreement, Other events

Mar 24

Current report 8-K

Financial results

Mar 24

Annual report 10-K FY2024, ended Dec 31

Annual report for FY2024

Revenue $925K Net loss $75.14M Diluted EPS -$4.28

Mar 24

Registration statement S-3

Registration statement

Jan 13

Current report 8-K

Regulation FD disclosure

Dec 2

Registration statement S-1

Registration statement

Nov 21

Current report 8-K Events of Nov 20

Regulation FD disclosure

Nov 18

Current report 8-K

Regulation FD disclosure

Nov 18

Current report 8-K

Financial results

Nov 18

Quarterly report 10-Q FY2024 Q3, ended Sep 30

Quarterly report for FY2024 Q3

Revenue $0 Net loss $20.22M Diluted EPS -$1.19

Nov 14

Late filing notice NT 10-Q

Late filing notice

Nov 12

Current report 8-K Events of Nov 11

Regulation FD disclosure

Nov 4

Current report 8-K

Entered into a material agreement, Unregistered sale of equity, Regulation FD disclosure

Aug 9

Current report 8-K

Financial results

Aug 9

Quarterly report 10-Q FY2024 Q2, ended Jun 30

Quarterly report for FY2024 Q2

Revenue $925K Net loss $18.49M Diluted EPS -$1.09

Aug 7

Current report 8-K

Regulation FD disclosure

Jun 21

Current report 8-K

Regulation FD disclosure

Jun 18

Current report 8-K

Regulation FD disclosure

Jun 17

Current report 8-K Events of Jun 14

Shareholder vote results